Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

History, applications, and mechanisms of deep brain stimulation.
Clinical Proton MR Spectroscopy in Central Nervous System Disorders.
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Combined oral contraceptives: health benefits beyond contraception.
Automatic white matter lesion segmentation using an adaptive outlier detection method.
Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor beta.
Multiple sclerosis: a comprehensive review for the physician assistant.
Charcot-Marie-Tooth Disease Type 4H Resulting from Compound Heterozygous Mutations in FGD4 from Nonconsanguineous Korean Families.
Does multiple sclerosis affect glucose tolerance?
Nitrous oxide induced myeloneuropathy: a case report.
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study.
Melanoma complicating treatment with natalizumab for multiple sclerosis.
Developing a community multiple sclerosis nursing service.
Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles.
Mitochondrial changes within axons in multiple sclerosis: an update.
Seasonality of multiple sclerosis and neuromyelitis optica exacerbations in Japan.
Pain mechanisms in multiple sclerosis.
Lower physical activity is associated with higher disease burden in pediatric multiple sclerosis.
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.
Case Studies: LAAM, Naltrexone, Clozapine, and Nicorette
Association between parasite infection and immune responses in multiple sclerosis.
Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values: Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D.
Effectiveness of Energy-Conservation treatment in reducing fatigue in Multiple Sclerosis: a systematic review and meta-analysis.
A randomized clinical trial of valacyclovir in multiple sclerosis.

Pages